Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS

被引:42
作者
Vanhems, P
Hirschel, B
Phillips, AN
Cooper, DA
Vizzard, J
Brassard, J
Perrin, L
机构
[1] Univ Lyon 1, Lab Epidemiol & Publ Hlth, INSERM, U271, F-69373 Lyon 08, France
[2] Hop Edouard Herriot, Epidemiol Unit, Lyon, France
[3] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland
[4] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England
[5] UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London, England
[6] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[7] Univ Montreal, Inst Social & Prevent Med, Montreal, PQ, Canada
关键词
D O I
10.1086/315687
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The severity and the duration of acute human immunodeficiency virus (HIV) infection (AHI) are associated with a faster rate of progression to AIDS, but the prognostic value of the length of incubation time of AHI (IncAHI), defined as the time between HIV infection and AHI, on progression to AIDS has not been assessed. We explored this issue prospectively in 70 individuals with documented AHI and a known date of HIV infection. The median IncAHI was 21.5 days (range, 5-70 days), and the median duration of AHI was 15.5 days (range, 3-67 days). The adjusted relative hazard of progression to AIDS or to a CD4(+) count <200 X 10(3)/mL was 4.23 (95% confidence interval [CI], 1.40-12.73; P = .01) for the patients with an IncAHI <21.5 days, compared with those with longer IncAHI, and was 3.53 (95% CI, 1.09-11.36; P = .03) for the patients with a duration of AHI >15.5 days, compared with those with shorter duration. Both IncAHI and duration of AHI were independent predictors of progression. This suggests that early pathogenic events before the onset of AHI influence the rate of HIV disease progression.
引用
收藏
页码:334 / 337
页数:4
相关论文
共 15 条
[1]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[2]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[3]   CLINICAL PICTURE OF PRIMARY HIV INFECTION PRESENTING AS A GLANDULAR-FEVER-LIKE ILLNESS [J].
GAINES, H ;
VONSYDOW, M ;
PEHRSON, PO ;
LUNDBERGH, P .
BRITISH MEDICAL JOURNAL, 1988, 297 (6660) :1363-1368
[4]   Occupational human immunodeficiency virus infection in health care workers: Worldwide cases through September 1997 [J].
Ippolito, G ;
Puro, V ;
Heptonstall, J ;
Jagger, J ;
De Carli, G ;
Petrosillo, N .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :365-383
[6]   Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection [J].
Musey, L ;
Hughes, J ;
Schacker, T ;
Shea, T ;
Corey, L ;
McElrath, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18) :1267-1274
[7]  
OKSENHENDLER E, 1986, NEW ENGL J MED, V315, P582
[8]   CLINICAL COURSE OF PRIMARY HIV INFECTION - CONSEQUENCES FOR SUBSEQUENT COURSE OF INFECTION [J].
PEDERSEN, C ;
LINDHARDT, BO ;
JENSEN, BL ;
LAURITZEN, E ;
GERSTOFT, J ;
DICKMEISS, E ;
GAUB, J ;
SCHEIBEL, E ;
KARLSMARK, T .
BRITISH MEDICAL JOURNAL, 1989, 299 (6692) :154-157
[9]   Reduction of HIV concentration during acute infection: Independence from a specific immune response [J].
Phillips, AN .
SCIENCE, 1996, 271 (5248) :497-499
[10]   In vivo HIV-1 replicative capacity in early and advanced infection [J].
Phillips, AN ;
McLean, AR ;
Loveday, C ;
Tyrer, M ;
Bofill, M ;
Devereux, H ;
Madge, S ;
Dykoff, A ;
Drinkwater, A ;
Burke, A ;
Huckett, L ;
Janossy, G ;
Johnson, MA .
AIDS, 1999, 13 (01) :67-73